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Abstract  
In eukaryotes, gene expression is regulated at different levels, including transcription 
and RNA processing. Alternative polyadenylation in the 3’untranslated region during pre-mRNA 
processing has a fundamental role in different biological processes and disease.  
In this thesis, using the genes polo and CG6024 as a model, the impact of an increased 
RNA polymerase II elongation rate on alternative polyadenylation is characterized in a D. 
melanogaster mutant (RpII140) that has 50% faster transcription elongation rate. The model 
genes contain two pA signals, with opposite efficiency strengths, which are used to produce two 
mRNA isoforms with different 3’UTR lengths. It was observed a decrease of total and pA1 mRNA 
levels and different results regarding pA2 mRNA levels in both genes, in this mutant fly. These 
results suggest that faster RNA polymerase II elongation rate reduces the 3’end formation 
efficiency. 
In addition, polo poly(A) site usage was determined when the elongation factors dELL 
and dSpt6 were depleted via RNAi. It was observed that dELL enhances the usage of polo 
proximal poly(A) site. The results for dSpt6 were inconclusive due to variations in the expression 
of the reference gene used (7SL). 
The work described in this thesis shows an important role of the RNA polymerase II 
elongation rate in alternative polyadenylation and also suggests a role of dELL in poly(A) site 
choice.  
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Chapter 1  
Introduction 
 
In eukaryotic cells, the molecular processes involved in messenger RNA (mRNA) 
production are certainly among the most complex events in cellular biology and biochemistry. In 
fact, it is not only necessary a diverse set of factors to start RNA synthesis and the elongation of 
the RNA chain, but also the accurate processing of the primary RNA transcript is extremely 
complex (Darnell 2013).  
In the past, pre-mRNA processing events were thought to occur independently, until 
several experiments revealed that these mechanisms are tightly coupled to RNA polymerase II 
(Pol II) transcription, i.e. they are mostly co-transcriptional (Bentley 2014). Currently, the term co-
transcriptional has come to imply a functionally significant coupling between transcription and 
RNA processing events, and since these processes are involved in the fine-tuning of gene 
expression, a great interest has been arising to understand the interplay between these two 
events.  
 
 
1. Elongation: a crucial point not only in the 
transcription cycle 
 
It is well established that transcription is one of the most highly regulated phenomenon 
in eukaryotic gene expression. This process is carried out by orthologous enzymes, multi-subunit 
DNA-dependent RNA polymerases (RNAPs) and essentially is comprised by three phases that 
are mechanistically distinct: initiation, elongation and termination (Svetlov & Nudler 2013; 
Palangat & Larson 2012).  The first stage consists in the promoter recognition and opening of the 
DNA helix. In the next phase RNAPs extends the RNA transcript, and in the termination stage, 
dissociation of the RNA–DNA hybrid occurs with the nascent transcript being released from the 
DNA template (Nechaev & Adelman 2011; Palangat & Larson 2012). The cycle of eukaryotic 
transcription by Pol II is a complex and regulated event. Unquestionably, it is the coordinated 
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action of regulatory factors that assures the transcriptional competence of Pol II at different 
phases (Kwak & Lis 2013). 
Transcription is a precisely timed event. It starts with the recruitment of RNA polymerase 
and general transcription factors (GTFs) to a target gene promoter. The recognition of the 
promoter begins with a sequence-specific binding of an activator to the enhancer DNA elements 
that stimulates the assembly of a large protein complex containing Pol II and multiple GTFs (TFIIB, 
TFIID, TFIIE, TFIIF and TFIIH) known as pre-initiation complex (PIC). This PIC undergoes a series 
of transformations as the nascent RNA is synthesized, and the key modification is the local melting 
of the DNA around the transcription start site (TSS) in which a double stranded promoter 
transforms to an single stranded promoter complex. The subsequent events as de novo RNA 
synthesis (formation of the first phosphodiester bond), abortive initiation (in which short transcripts 
are continually synthesized and released by polymerase still associated with the promoter), and 
promoter escape (a stage characterized by physical and functional instability of the transcription 
complex) precedes transcript elongation (Liu et al. 2013; Nechaev & Adelman 2011). During 
transcription initiation the initial length of the nascent transcript is crucial, since transcripts of less 
than 5 nucleotides (nt) are unstable (which results in a high frequency of abortive initiation), 
transcripts with 10 nt display a preference for promoter escape over abortive initiation and 
transcript with length of around 25 nt achieve productive initiation and consequently transcription 
elongation initiates (Saunders et al. 2006). 
At this point, the initiation-elongation transition starts with the dissociation of initiation 
factors and recruitment of elongation factors to the Pol II transcription complex (Lidschreiber et 
al. 2013; Zhou et al. 2013). Elongation extends nascent RNA by one nucleoside monophosphate 
with pyrophosphate release, followed by Pol II translocation along the template by one nucleotide 
(Svetlov & Nudler 2013). Interestingly, in metazoans, Pol II elongation throughout a gene is not 
always a uniform event, since after transcription of the first ∼20–60 nts Pol II pauses. This is a 
crucial step for approximately half of all active Drosophila and mammalian genes because the 
progress beyond this point is rate limiting. Therefore, many authors consider elongation as a 
process composed by two distinct stages: early elongation and productive elongation (Kwak & Lis 
2013). 
1.1. Pausing vs Productive elongation 
Pol II is able to transit between promoter escape and fully productive elongation and 
often this event is complemented with an intermediate step of promoter-proximal pausing which 
is known as early elongation. After initial elongation of nascent RNA (up to ∼10 nts), Pol II is 
capable of escaping the initiation stage. At this point GTFs such as TFIIB dissociate, however 
parts of the initiation complex may remain connected to the promoter in order to provide a scaffold 
for re-initiation. Once the transcript is longer than 12 nts and TFIIB is removed, the Pol II 
elongation complex becomes stably engaged and the early elongation stage begins. During the 
Integrating RNA Polymerase II dynamics with alternative polyadenylation 
Joana Troça Correia Maia 
 
3 
 
course of early elongation in higher eukaryotes, Pol II pauses after transcribing ∼20–60 nts. Pol 
II is most likely to be found in an arrested state (backtracked position), but the enzyme can be 
rescued from that state by binding the TFIIS, which stimulates cleavage of protruded nascent 
RNA and realignment of the new pre-mRNA 3’ end with the Pol II active site (Saunders et al. 
2006; Kwak & Lis 2013; Nechaev & Adelman 2011). Additionally, in vitro studies demonstrate that 
the early elongation complex has a strong tendency to pause, arrest and terminate transcription, 
which highlights the inefficiency of the event. This feature of the early elongation complex can 
have multiple reasons, including negative action of some elongation factors that inhibit synthesis 
through the promoter-proximal region or the fact that the early elongation complex need to 
experience some conformational modifications in order to became fully stable and processive 
(Nechaev & Adelman 2011). 
Pioneering studies revealed that many factors and specific promoter features are 
essential for full regulation of early elongation, disclosing another critical layer of transcription 
control. Indeed, the early elongation mechanisms are connected to the promoter structure, which 
affects both transcriptional initiation and pausing (Gilchrist et al. 2010; Kwak & Lis 2013). Two 
main factors regulate Pol II pausing, the DRB sensitivity-inducing factor (DSIF) and the negative 
elongation factor (NELF), through binding to and inhibiting Pol II function (Marshall & Price 1992; 
Mandal et al. 2004). Regarding the functional role of transcriptional pausing, recent works suggest 
that the ability of Poll to pause modulates transcription kinetics, output, or the coordination of gene 
activation. Moreover, the potential of this event as a fine-tuned mechanism of regulating gene 
expression levels in response to a changing environment has been discussed (Adelman et al. 
2009; Boettiger & Levine 2009; Nechaev & Adelman 2011). 
To enter the stage of productive elongation Pol II needs to escape from early elongation 
which requires a dynamic transition from the paused state into its subsequent reinstatement in a 
productive mode (Kwak & Lis 2013). This shifting requires a highly controlled exchange of factors 
that is orchestrated mainly through phosphorylation of the C-terminal domain (CTD) of the largest 
Pol II subunit (Rpb1). This domain consists of tandem heptapeptide repeats (27–52) of the 
consensus sequence, YSPTSPS. Each repeat bears three serine residues (Ser2, 5 and 7) and a 
threonine residue (Thr4) that undergo reversible phosphorylation by CTD-modifying enzymes at 
specific stages of transcription, in the so-called the “CTD code” (Buratowski 2005; Hintermair et 
al. 2012; Heidemann et al. 2013; Egloff et al. 2012; Hsin & Manley 2012). During the transition 
from transcription initiation to elongation, Pol II changes from a hypophosphorylated to a 
hyperphosphorylated form. It is noteworthy that the various CTD modifications can affect Pol II 
conformation and ability to associate with different factors which modulate various events, 
including pre-mRNA processing, in particular 3’ end formation (McCracken et al. 1997; Saunders 
et al. 2006). 
In order to accomplish the transition into productive elongation recruitment of the 
positive transcription elongation factor (P-TEFb) is necessary. In fact, P-TEFb is able to reverse 
Integrating RNA Polymerase II dynamics with alternative polyadenylation 
Joana Troça Correia Maia 
 
4 
 
the negative influence of DSIF and NELF by phosphorylating the largest component of pausing 
factors subunits (Suppressor of Ty (Spt) 5). This event also stimulates the function of TFIIF in 
productive transcription. Furthermore, P-TEFb phosphorylates other targets such as Ser-2 CTD, 
which help transcription through chromatin and pre-mRNA processing (Moore & Proudfoot 2009; 
Saunders et al. 2006).  
 Even after pause escape, Pol II still must surmount some roadblocks to achieve a 
dynamic environment for productive transcription. Consequently some specific post-translational 
modifications on the CTD and on the N-terminal histone tails of the nucleosome are necessary 
(Shandilya & Roberts 2012). Indeed, the organization of eukaryotic DNA into chromatin severely 
affects Pol II progress into productive elongation or even transcription termination (Gilchrist et al. 
2010; Mischo & Proudfoot 2013). In many cases histone modifiers such as Spt6 (that remove 
nucleosome barriers by interacting directly with histones H3 and H4 and  help to render the DNA 
template accessible for productive elongation (Bortvin & Winston 1996). 
The overall transcriptional elongation rate relies on the balance between positive and 
negative regulatory factors, as well as on the chromatin conformation (Table 1). It must be 
highlighted that some elongation factors are associated to Pol II and enhance the elongation rate 
essentially by suppressing pausing factors (Palangat & Larson 2012).  
Elongin and eleven-nineteen lysine-rich leukemia gene (ELL) are well described 
families of proteins that are able to increase the catalytic rate of Pol II (Lin et al. 2013; Kwak & Lis 
2013). Recently, Lin et al. identified the super elongation complex (SEC), comprising the ELL 
family of Pol II elongation factors (ELL1, 2 and 3) and the positive transcription elongation factor 
P-TEFb, as many of the most frequent mixed lineage leukemia translocation partners. (Lin et al. 
2010).  In fact, SEC was found to regulate the transcriptional elongation checkpoint control 
(TECC) stage, which is an extremely relevant step in transcription, since it refers to the regulation 
of Pol II assembly and release from the paused stage. The TECC stage is crucial for the regulation 
of gene expression during development and its misregulation is associated with various diseases, 
including cancer (Smith, Lin & Shilatifard 2011).  
Overall, these examples illustrate how much remains to be discovered regarding the 
already known elongation factors, and also suggest that the repertoire of proteins that affect 
elongation has not yet been completely revealed. 
The entire transcription cycle is coordinated with other essential events that lead to 
proper processing of RNA. Indeed, as mentioned before, the CTD is not only subject to a plethora 
of post-translational modifications, but also acts as a scaffold for the recruitment of several factors 
involved in distinct stages of transcription as well as in co-transcriptional processes such as pre-
mRNA 5’ capping, splicing and 3’ end formation  (Lidschreiber et al. 2013; Moore & Proudfoot 
2009). Therefore, the interactions between transcription factors and processing machineries form 
a tight regulated network of cross-stimulatory connections with a  role on pre-mRNA processing 
(Mapendano et al. 2010).  
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Table 1- List of the most relevant factors involved in transcription elongation 
 
1.2. Elongation as a regulator of gene expression 
In the past it was generally assumed that gene expression regulation took place only 
via promoters and enhancers, i.e. at the transcription initiation step. Nevertheless, now it is 
generally recognized that gene expression can be regulated at all steps of the transcription cycle, 
with an emphasis at the level of transcription elongation (Svejstrup 2013; Proudfoot 2004). 
Therefore, it has been a significant paradigm shift in the transcription field, since the elongation 
event is now appreciated as significant regulator of gene expression.(Svejstrup 2013).  
Class Factor  Properties References 
General 
transcription 
factors 
TFIID Assists in promoter structure for pausing  (Shopland et al. 1995) 
TFIIF Increases elongation rate 
(Bengal et al. 1991; Tan et al. 
1995) 
TFIIS Rescues backtracked Pol II  
(Bengal et al. 1991; 
Kettenberger et al. 2004) 
Pausing factors 
NELF Stabilizes Pol II pausing 
(Narita et al. 2003; 
Yamaguchi et al. 1999) 
DSIF Stabilizes Pol II pausing  and facilitates elongation 
(He et al. 2011; Yamada et 
al. 2006) 
Positive 
elongation 
factor 
P-TEFb 
Stimulates pause release by phosphorylating 
NELF, DSIF, and Pol II CTD 
(Kim & Sharp 2001) 
Processivity 
factors 
Elongin Alleviates pausing, increases Pol II rate (Aso et al. 1995) 
ELL Alleviates pausing, increases Pol II rate (Lin et al. 2013) 
SEC Contains  ELL and P-TEFb (Lenasi & Barboric 2010) 
Co-activator Mediator Recruits P-TEFb via SEC (Takahashi et al. 2011) 
Polymerase 
associated-
complex 
PAF Platform to elongation factors assembly (e.g SEC) (He et al. 2011) 
Histone tail 
modifiers 
SET1 
Methylates histone H3-K4, localized to promoter 
and coding region 
(Krogan et al. 2003) 
SET2 
Methylates histone H3-K6, localized to coding 
regions 
(Krogan et al. 2003) 
Histone 
chaperone 
Spt6 H3-H4 chaperone and Tracks with Pol II  (Saunders et al. 2003) 
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The relevance of transcriptional elongation as a regulator of gene expression has just 
recently been recognized. In fact, recent work demonstrates that transcription elongation can 
adjust the outcome of gene expression, since it modulates cellular RNA levels, essential for a 
diverse range of biological pathways, differentiation, development and survival of all cells and 
organisms (Jennings 2013; Kwak & Lis 2013; Smith & Shilatifard 2013; Svejstrup 2013). 
Furthermore, deregulation of elongation can lead to the development of certain diseases (Li & 
Green 1996). 
As mentioned before, transcription elongation factors have different functions, such as 
modulating the catalytic properties and processivity of Pol II and assisting the progression of the 
enzyme through repressive chromatin. Besides that, it is also described that these factors can 
have an impact in gene expression by modulating the elongation stage (Saunders et al. 2006). 
Indeed, this additional role of elongation factors is illustrated by Dürr et al.’ s work, which showed 
that elongation factors Spt4/Spt5 can modulate the expression of Arabidopsis genes transcribed 
by Pol II, particularly influencing the transcription of genes involved in auxin signalling (Dürr et al. 
2014) . Furthermore, Chopra et al. presented genetic and molecular evidence that the Drosophila 
Hox genes are subject to an additional layer of regulation at the level of elongation, since the Pol 
II elongation factors Elongin-A and Cdk9 proved to be essential for optimal Ultrabithorax (Ubx) 
and Abdominal-B (Abd-B) expression (Chopra et al. 2009).  
Additionally, elongation can regulate gene expression by a functional coupling with 
other molecular events. As previously stated, many pre-mRNA processing events occur co-
transcriptionally, therefore is not surprising that some processing events are affected by 
transcription, namely by elongation (Howe 2002). This is the case for splicing, which was shown 
that it is functionally coupled to transcription by correlating Pol II elongation rate with the ability of 
splicing factors to recognize splice sites of various strengths (Dujardin et al. 2014). As an example, 
Robert et al. showed that in α-tropomyosin gene, slower elongation favours utilization of weaker 
upstream splicing sites (Roberts et al. 1998). Consequently, the coupling between elongation and 
processing events, such as splicing, help cells to modulate the levels of expressed proteins and/or 
produce multiple protein isoforms from one single transcriptional unit. 
 
 
 
2. Alternative Polyadenylation in the 3’ end formation 
 
To obtain a mature mRNA the primary RNA transcript (pre-mRNA) needs to be 
processed. Pre-mRNA processing includes various steps that are mostly co-transcriptional: 
capping, editing, splicing and polyadenylation (Lutz & Moreira 2010; Yang & Doublié 2011; 
Neugebauer 2002).  
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During 5’ end cap modification, the 5′ triphosphate of the pre-mRNA is cleaved and a 
guanosine monophosphate is added which is subsequently methylated (Lewis & Izaurralde 1997). 
The addition of the 5′ cap provide resistance of the mRNA molecule to 5′ to 3′ exonucleases, 
which expands the (pre)-mRNA lifetime. Additionally, the 5’ cap interacts with protein factors 
involved in other cellular processes such as pre-mRNA splicing, nucleocytoplasmic RNA export 
and localization and translation (Cougot et al. 2004; Neugebauer 2002). 
RNA editing is a modification of individual RNA residues which are converted to 
alternative bases. These base modifications are performed by adenosine deaminases acting on 
RNA (ADAR) that substitute adenosine to inosine (A-to-I editing), or by apolipoprotein B mRNA 
editing enzyme (APOBEC1), which converts cytosine with uracil. This process increases the 
complexity of the mRNA isoforms at the single-base level and consequently may result in an 
amino acid sequence change in the protein, in differences in alternative splicing decisions or in 
nuclear retention of the transcript (Dillman et al. 2013; Jin et al. 2007; Garncarz et al. 2013). 
Another significant process in mRNA maturation is the precise removal of noncoding 
sequences (introns) and the joining of the remaining sequences (exons) in a multistep reaction, 
a process known as RNA splicing. This modification is mediated by a catalytically active form of 
a megacomplex named the spliceosome (Montecucco & Biamonti 2013; Dujardin et al. 2013). It 
is noteworthy that some introns can be retained and particular exons can be entirely or partially 
skipped, therefore more than one mRNA molecule from a single transcriptional unit can be 
produced by alternative splicing. These splicing events have the biological advantage of 
increasing the proteome diversity, since they allow the same transcriptional unit to produce many 
diverse proteins that may have different localizations, stabilities and functions (Dujardin et al. 
2013; Alberts et al. 2008; Sanchez et al. 2011). In addition to the production of a new proteins, 
alternative splicing may shift the reading frame which may result in transcripts with premature 
stop codons  (Lewis et al. 2003; Resch et al. 2004). Some splicing events were shown to be 
regulated in response to different cell stimuli which ensure the production of the right proportion 
of the different isoforms in the different occasions (Castro et al. 2007; da Glória et al. 2014). In 
fact, in order to guarantee plasticity, high specificity and fidelity, the alternative splicing process 
requires a very precise regulation (Nogués et al. 2003; Dujardin et al. 2013).  
The generation of mature mRNAs also requires correct 3′ end processing. mRNA 3’ end 
formation requires two tightly coupled steps involving an endonucleolytic cleavage of the nascent 
transcript, followed by the polymerization of the adenosine tail (polyadenylation reaction) (Rehfeld 
et al. 2013).  
In eukaryotes, polyadenylation of transcripts generated by Pol II is an essential step of 
gene expression and also a versatile mechanism of gene regulation (Colgan & Manley 1997; 
Zhao & Hyman 1999; Millevoi & Vagner 2010; Shepard et al. 2011). Effective pre-mRNA 3’ end 
cleavage requires a core molecular machinery that includes four multisubunit protein complexes: 
cleavage and polyadenylation specificity factor (CPSF), cleavage stimulation factor (CstF), 
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cleavage factors Im and IIm (CFIm and CFIIm) (Gruber et al. 2013; Yang & Doublié 2011). At the 
3’ end of the upstream cleavage product, a poly(A) tail is added by nuclear poly(A) polymerases 
(PAP), α (PAPOLA), β (PAPOLB), or γ (PAPOLG). The length of the poly(A) tail  is determined 
by the nuclear poly(A)-binding protein 1 (PABPN1), although the length greatly differ between 
species (Gruber et al. 2013; Wahle 1991; Wahle & Keller 1996; Banerjee et al. 2013). It is worth 
to emphasize the importance of the poly(A) tail length, since it can affect the enzymatic 
degradation and the translationally dormant state of the mRNA in certain developmental stages 
(Jalkanen et al. 2014; Guhaniyogi & Brewer 2001).  
The described 3’ processing mechanism displays a high level of complexity that is 
fundamental to ensure its precise regulation, crosstalk between other steps of gene expression 
and also to define the proper definition of the cleavage site (Yang & Doublié 2011; Tian & Manley 
2013; Moore & Proudfoot 2009). Furthermore, the correct poly(A) site is recognized through a 
tripartite mechanism coordinated by coupled interactions between 3’ processing factors and RNA 
sequence elements (Millevoi & Vagner 2010; Yang & Doublié 2011; Shi 2012). These sequence 
elements are called cis-elements, and almost all the eukaryotic poly(A) signals contain multiple 
cis-elements that include the consensus sequence AAUAAA or variants of these, a U- or GU-rich 
downstream element (DSE), and a U-rich upstream stimulatory element (USE) (Shi 2012) (Figure 
1). 
 
 
 
Figure 1 - Schematic representation of the cis-acting elements involved in 3’end formation 
 
The poly(A) signal was first described as the hexamer AAUAAA by Proudfoot and 
Brownlee (Proudfoot & Brownlee 1976). Although this hexamer is present in the vast majority of 
the genes, variants also exist. In humans, the canonical poly(A) signal is present in  48-69 % of 
the genes and the most common variation of this signal is a single A-U nucleotide substitution on 
the second position (AUUAAA), which is present in 12-16% of the genes. Additionally, other 
variants are also present in the genome: 20% of these display single  nucleotide  variants  in the   
AAUAAA hexamer and  10%  do  not  have  a  recognizable  AAUAAA-like sequence (Tian et al. 
2005).   
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It is noteworthy that variations of the canonical poly(A) signal result in significant 
changes in cleavage and polyadenylation activity. In fact, it is described that the most efficient 
hexamer is the canonical one and all other non-canonical signals display a strong efficiency 
reduction. Interestingly, the only variant with a similar activity to the canonical poly(A) signal 
described  is the AUUAAA (Wilusz et al. 1989; Sheets et al. 1990) (Figure 2). 
Notably, a correlation between the type of poly(A) signal  and  its  location can be made.  
In fact, it has been shown that the 3´ end of the transcripts display the highest frequency of 
AAUAAA hexamer (Hu et al. 2005). This difference  in  the sequence of the poly(A) signals  
supports  the  notion  that  the  3’ most  poly(A) signals  are typically  strong,  ensuring  proper  
termination  of  transcription,  and upstream  signals  are  weak,  allowing  regulation to occur.  
 
 
Figure 2- Diverse poly(A) signals and their  polyadenylation efficiency (Adapted from Weaver 2012)  
2.1. Alternative polyadenylation and gene expression 
Most eukaryotic genes display mRNAs with multiple alternative 3’ ends formed by 
polyadenylation at distinct sites, a phenomenon known as alternative polyadenylation (reviewed 
by Tian & Manley 2013; Lutz & Moreira 2010; Hsin & Manley 2012). In recent years it has become 
increasingly evident that alternative polyadenylation is much more pervasive than previously 
appreciated, since the latest estimate is that ~80% of human genes (Derti et al. 2012) and ~54% 
of Drosophila genes (Smibert et al. 2012) encode multiple transcripts derived from alternative 
polyadenylation.  
Here is presented the classification of alternative polyadenylation in higher eukaryotes 
into three general events suggested by Lutz in 2008 (Figure 3). The type I polyadenylation 
involves the presence of one polyadenylation signal in the 3’ UTR leading to only one resulting 
mRNA. In type II alternative polyadenylation, more than one polyadenylation signal is present in 
the common terminal exon, which leads to more than one mRNA isoform. In this type of 
polyadenylation the encoded protein is the same, however the expression may be affected by 
regulatory sequences present in the 3’UTR and cause changes in mRNA stability, localization or 
translation competence.  The type III alternative polyadenylation refers to alternative 
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polyadenylation signals present in upstream introns or exons. In this way, the alternative 
polyadenylation is coupled with alternative splicing and it is possible to define type IIIi or type IIIe 
alternative polyadenylation regarding the position of the alternative polyadenylation signals, since 
they can be intronic (type IIIi) or exonic (type IIIe). These types of alternative polyadenylation may 
result in different protein products and also influence  mRNA stability and translatability, or even 
lead to the insertion of an in-frame stop codon  (Lutz 2008; Lutz & Moreira 2010).  
 
  
 
Figure 3- Schematic representation of polyadenylation events. Grey boxes, 5’ untranslated regions; 
Green boxes, 3’ untranslated regions; orange and blue boxes, coding regions; lines, introns.  
 
Regarding the types of polyadenylation depicted, it is noteworthy that alternative 
polyadenylation contributes to increase the transcriptome complexity by producing isoforms with 
different coding sequence or 3′UTRs. Differential processing at multiple poly(A) sites in the 3’UTR 
could display important biological functions, since it plays a crucial role in gene expression’s 
control  (Fabian et al. 2010; Andreassi & Riccio 2009).  
Alternative polyadenylation produces mRNA isoforms with different 3’UTRs containing 
different cis-acting elements. Since these cis-elements may harbour microRNA (miRNA)-target 
sites or binding sites for RNA-binding proteins the diversity of isoforms produced may affect gene 
expression quantitatively (Lutz & Moreira 2010). Therefore, longer 3’ UTRs will more likely 
possess such elements and the mRNA will be more likely susceptible to regulation. Generally, 
shorter transcripts with shorter 3’ UTRs produce higher levels of protein, which indicates that the 
amount of protein generated is dependent on the 3’UTR length (Mayr & Bartel 2009; Sandberg et 
al. 2008; Ji et al. 2011).  
Another mechanism by which alternative polyadenylation affects protein expression is 
by regulating mRNA localization. In fact, alternative polyadenylation is able to modulate cis-
elements found within the 3’ UTR that dictated the localization of the mRNA (Andreassi & Riccio 
2009). The control of the mRNA localization can be extremely important, for instance to promote 
rapid local protein synthesis in differentiated neurons (Di Giammartino et al. 2011). 
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The role of alternative polyadenylation in the regulation of different cellular states and 
programs such as proliferation, differentiation, and development programs is crucial, since it 
allows accurate regulation of a number of genes in a very precise manner (Lutz & Moreira 2010). 
In fact, through genome-wide analysis of alternative polyadenylation, it was possible to define a 
pattern that relates the proliferation and differentiation status of cells with the length of 3’ UTRs. 
It was showed that proliferation and dedifferentiation are associated with a general shortening in 
3’ UTR length due to proximal poly(A) site usage, while 3’ UTRs tend to be longer  by distal poly(A) 
site usage during late developmental stages and differentiation processes (Rehfeld et al. 2013; 
Elkon et al. 2013). 
Almost all the biological processes rely on accurate gene regulation in a precise 
temporal and spatial manner. As mentioned before, the alternative polyadenylation is a key player 
in the control of gene expression, therefore dysfunctional polyadenylation may be lead to a 
number of diseases and their progression (Mayr & Bartel 2009). Indeed, loss or gain of poly(A) 
sites in functionally important genes can be accomplished by genetic mutations or single-
nucleotide-polymorphisms, and this phenomenon can cause or contribute to various diseases 
(Shi 2012; Curinha et al. 2014).   
The association between diverse biological and pathophysiological processes and 
extensive alternative polyadenylation modulation indicates that poly(A) site selection is under 
precise and vigorous control. The regulatory mechanisms that control alternative polyadenylation 
are now coming into light and they form the rules that guide the poly(A) site choice that were 
coined by Yongsheng Shi as the “polyadenylation code” (Shi 2012). 
2.2. Regulatory mechanisms of alternative polyadenylation 
One well established  alternative polyadenylation regulatory theme is the expression 
level of components of the 3′-end-processing machinery, since the levels of the core 3’ processing 
factors can modulate the poly(A) site selection (Shi 2012; Elkon et al. 2013). A well-known 
example of this model of action occurs during B cell differentiation. It was described that during 
B-cell activation high protein levels of CstF64 (a core 3’ processing factor) promote the usage of 
a proximal poly(A) signal in the IgM mRNAs that contains a weak CstF64 binding site. However, 
in resting B cells, which have a limited resource of CstF64, the distal poly(A) signal with a strong 
CstF64 binding site is preferentially recognized (Takagaki et al. 1996). Consequently, higher 
levels of 3’ processing factors in proliferating cells may promote the recognition of weaker poly(A) 
sites, while the limited amounts of 3’ processing factors in differentiated cells may be preferentially 
recruited to the stronger poly(A) sites (Shi 2012). 
Several  studies suggest that specific RNA-binding proteins (RBPs) are also involved in 
the control of alternative polyadenylation since they bind in close proximity to poly(A) sites, 
modifying the efficiency of  cleavage/polyadenylation at those sites. One recent  example is 
PABPN1 that suppresses weak poly(A) sites that results in an enhancement of polyadenylation 
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at stronger sites; since generally stronger sites are more distal, PABPN1 represses the proximal 
sites cleavage (Rehfeld et al. 2013; Shi 2012). Interestingly, a mutation of PABPN1 gene can 
cause the disease oculopharyngeal muscular dystrophy (OPMD), in which the most prevalent 
form of the disease results from a GCN expansion within in the first exon of the PABPN1 gene 
(Brais et al. 1998; Banerjee et al. 2013). Therefore, OPMD and PABPN1 provide an example of 
the development of a human pathology by a mutation in a core polyadenylation factor. 
Alternative polyadenylation is likely to be also modulated by cell signalling pathways. 
Although little is so far known about this mechanism, a potentially interesting example is the 
process that up-regulates the levels of the protease thrombin under conditions of stress, which is 
achieved through 3’ end processing regulation (Poort et al. 1996; Gehring et al. 2001; Danckwardt 
et al. 2011). 
It is now appreciated that all the steps of mRNA biogenesis are intertwined and 
interconnected. The functional coupling between transcription and 3′ end processing is well 
documented and an explanation for this coupling is that it serves to increase the efficiency by 
which nascent transcripts are cleaved. However, the impact of this link on alternative 
polyadenylation regulation is just beginning to be elucidated. So far, some studies have emerged 
in regarding this association of transcription and alternative polyadenylation.  In 2011, using a 
heterologous system, Nagaike et al. showed that transcriptional activators enhance processing 
efficiency and suggested that increasing the efficiency of 3’ processing along transcribed genes 
would tend to favour the use of proximal poly(A) sites. In support of this model, it was also shown 
that the knockdown of the transcription elongation complex PAF1C lead to an accumulation of 3’ 
extended transcripts of the target gene, since it resulted in the decrease of the 3′ cleavage and 
nuclear export of mRNA (Nagaike et al. 2011) . 
At the same time, a second principle emerged regarding the interplay between 
transcription elongation rate and alternative polyadenylation with the work of Pinto et al. In this 
study, it was shown that Pol II elongation rate has an important role in poly(A) site selection, since 
a Drosophila melanogaster mutant strain, containing a point mutation in RbpI that results in a 
reduced transcription elongation rate, displayed an increase in proximal poly(A) site usage in a 
number of transcripts. A mechanistic explanation for these findings relies on the fact that proximal 
poly(A) sites are transcribed first and are encountered first by the 3′-end- processing machinery. 
Therefore, the use of proximal poly(A) sites should negatively correlate with transcription 
elongation rate (Pinto et al. 2011).  
Interestingly, this scenario resembles to the effect that a lower transcriptional rate has 
on alternative splicing (de la Mata et al. 2003). Additionally, the work of Pinto et al clearly 
demonstrated a link between alternative polyadenylation and specific cellular states, since it 
assessed in Drosophila the physiological function of alternative polyadenylation in the 3’UTR at 
the organismal level (Pinto et al. 2011). Transgenic flies without the polo proximal (pA1) or distal 
(pA2) poly(A) signals were made and it was shown that flies that lack pA2 cannot express 
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sufficient levels of Polo protein and die in the pupa stage of development with severe abdominal 
abnormalities. The biological impact of pA2 deletion revealed that pA2 selection by the 
polyadenylation machinery is essential for abdominal histoblast proliferation, development of the 
adult epidermis and viability of the transgenic fly. Overall, this study highlights that polo alternative 
polyadenylation controls Polo protein levels and  is tightly connected with cell cycle control, 
proliferation and the onset of metamorphosis (Moreira 2011).    
It is well established the existence of multiple associations between the splicing and 3′-
end-processing machineries. In the interplay between splicing and alternative polyadenylation 
regulation, it was demonstrated that splicing and polyadenylation factors interaction that occurs 
in terminal introns of pre-mRNAs enhance cleavage efficiency at 3′UTR poly(A) sites  (Boelens et 
al. 1993; Ashe et al. 1995; Berg et al. 2012). Importantly, it has been suggested that there is a 
dynamic competition between splicing and polyadenylation, since the intronic polyadenylation 
events are usually associated with long introns with weak 5’ splice sites, which require more time 
to be spliced out (Rehfeld et al. 2013). Another indication for the interaction between splicing and 
alternative polyadenylation regulation is that various splice factors have been shown to affect 
polyadenylation, such as NOVA (Licatalosi et al. 2008), PTB (Castelo-branco et al. 2004; Moreira 
et al. 1995) and U1 (Gunderson et al. 1994; Lou et al. 1998; Berg et al. 2012). 
Epigenetic modifications of DNA structure have recently been implicated as having 
multiple impacts on RNA transcription and processing. In fact, it was described in the imprinted 
mouse gene H13 an allele-specific poly(A) site usage. This event is influenced by methylation 
primarily at CpG islands, since alleles without methylation of the CpG island utilize a proximal 
poly(A) site, generating a truncated H13, while alleles with methylation of the CpG island, utilize 
downstream poly(A) sites (Wood et al. 2008) . 
Another factor implicated in alternative polyadenylation is nucleosome composition of 
the chromatin nearby the polyadenylation signals. It is described a decreased nucleosome density 
around poly(A) sites and an increased nucleosome density downstream of actively used poly(A) 
sites. Indeed, in genes with multiple poly(A) signals, a higher downstream nucleosome affinity 
was associated with higher polyadenylation signal usage (Rehfeld et al. 2013; Elkon et al. 2013). 
All of the described regulatory mechanisms seem to be relevant and some authors 
suggest that poly(A) site selection is likely to be under the combinatorial control of multiple 
mechanisms. Therefore, currently the major challenge in deciphering the ‘‘polyadenylation code’’ 
is to integrate all of the different mechanisms in a quantitative manner. The importance of 
understanding such a code is highlighted by the impact of alternative polyadenylation in gene 
expression in health and disease. 
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3. The interplay between transcriptional elongation and 
alternative polyadenylation regulation 
 
Alternative polyadenylation is a well-orchestrated process that presents plasticity, while 
still displays high specificity and fidelity. Therefore, alternative polyadenylation is an event with an 
accurate, multilayer and complex regulation, where transcription is one of the players 
(Danckwardt et al. 2008; Dujardin et al. 2013).  
Alternative polyadenylation and transcriptional elongation are spatiotemporally 
coordinated and even though great effort has been made to characterize the interplay between 
both events most of the questions still remain unanswered. Nevertheless, some insight on this 
subject have been achieved by applying the knowledge already obtained on the coupling between 
alternative splicing and transcription, since some valid and similar conclusions can also be applied 
to alternative polyadenylation (Moreira 2011).  
It is well established that alternative splicing is regulated by the relative abundance of 
splicing factors and also by a more complex process involving the transcription machinery. 
Indeed, transcription and splicing can occur co-transcriptionally and in certain situations splicing 
is tightly coupled to transcription (Kornblihtt et al. 2013). In order to explain how this coupling 
works two non-mutually exclusive models have been proposed based on specific recruitment of 
Pol II-associated factors, the recruitment coupling model, and on splicing regulation by 
transcription elongation rates, the kinetic coupling model (Nogués et al. 2003). Excitingly, growing 
evidence suggest that the named models might also apply for coupling of alternative 
polyadenylation and transcription.  
3.1. The kinetic model 
The kinetic coupling model predicts that the rate of Pol II elongation influences the 
outcome of splicing. This model was supported by numerous experiments from the Kornblihtt 
group, namely de la Mata’s work showing that decreased Pol II elongation rate stimulates 
fibronectin EDI inclusion (~4 fold) (de la Mata et al. 2003). Therefore, the kinetic model suggests 
that a slower elongation rate favour the inclusion of alternative exons governed by an exon 
skipping mechanism, while a fast elongation rate favours exclusion of these. Additionally, many 
studies showed that kinetic coupling depends on the sequence context and the specific 
combination of splicing regulators that are involved on the accessibility of cis-competing splice 
sites in pre-mRNA (de la Mata et al. 2003; Nogués et al. 2003). Truly, the influence that elongation 
rates have on splicing can be interpreted as being consistent with the ‘first come, first served’ 
model, first postulated 26 years ago (Aebi & Weissman 1987). 
In 2011, Pinto et al. showed that in addition to affect alternative splicing, the Pol II 
elongation rate also plays a role in alternative polyadenylation (Pinto et al. 2011). In this study, 
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the  direct function of Pol II elongation rate in polo poly(A) signal selection was studied in 
Drosophila melanogaster using the C4 fly mutant, as this shows a 50% slower transcription 
elongation rate than its wild-type counterpart. The polo gene is involved in many critical steps in 
the cell cycle (Sunkel & Glover 1988) and generates two mRNAs that differ in their 3'UTR length 
due to the usage of two tandem pA signals, AUUAAA (pA1, proximal) and AAUAUA (pA2, distal). 
Therefore, the two polo transcripts have the same open reading frame and code for the same 
protein (Llamazares et al. 1991). 
By using the C4 fly mutant the authors were able to show that when the elongation rate 
is reduced by 50%, the proximal poly(A) signal usage is increased by 3.5 fold than in the wild 
type. Presumably, transcription by the “slow” Pol II allows longer exposure of the pA1 signal in 
the nascent pre-mRNA that will be thus recognized by the polyadenylation machinery before Pol 
II reaches the distal pA signal (Figure 4). The influence that elongation rates have on alternative 
polyadenylation can be interpreted as being consistent with the ‘first come, first served’ model, 
first postulated for alternative splicing (Aebi & Weissman 1987). Moreover, using this mutant Pol 
II, a comparison can be drawn between the value obtained for the increase of proximal poly(A) 
signal usage (3.5 fold) (Pinto et al. 2011) and for alternative EDI exon inclusion (4-fold) (de la 
Mata et al. 2003). 
Indubitably, the most direct support for kinetic coupling has come from the use of C4 fly 
mutant , which harbour an amino acid substitution (change in amino acid 741 from Arg to His) in 
the RpII215 gene that encodes the largest subunit of Pol II and show a reduced elongation rate 
(Coulter & Greenleaf 1985; Chen et al. 1996). After the C4 fly mutant contribution to elucidate the 
kinetic interaction between alternative polyadenylation and elongation, a pertinent question 
raised: “Is the alternative polyadenylation pattern affected by an enhancement of Pol II elongation 
rate?”. Even though Pinto et al. suggested that a “fast” Pol II would favour the distal poly(A) signal 
usage (Figure 4), this  is still an enigma. Interestingly, a key tool to address this question would 
be a fly mutant able to display a phenotype opposite to that presented by C4. That mutant is the 
S1 fly mutant, which carries a mutation that alters amino acid 728 from Ser to Cys in RpII140 
gene which encodes the second largest subunit of Pol II and display a ~50% enhanced Pol II 
elongation rate (Coulter & Greenleaf 1985; Chen et al. 1996). Truly, with the tools to answer this 
question, it can only be imagined the new challenges that will appear when exploring this flied.  
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Figure 4- Proposed model by Pinto et al for the role of Pol II kinetics on polo poly(A) site selection 
(Adapted from Pinto et al 2011 and Moreira 2011) 
3.2. The recruitment model 
 The recruitment coupling model implies that the recruitment of factors by the 
transcription machinery will affect the subsequent splicing decisions. Examples of this model are 
transcription elongation regulator 1 (TCERG1) and DBC1–ZIRD (DBIRD) complex that are able 
to modulate selective exon skipping through the control of Pol II elongation (Montes et al. 2012; 
Close et al. 2012). 
In comparison to alternative splicing events, it is also possible that the coupling between 
alternative polyadenylation and transcription elongation occurs through recruitment of specific 
transcription elongation factors that influence the poly(A) site usage. Accumulating evidence 
indicates that transcriptional activity impacts poly(a) signal choice, since defects in the 
transcriptional elongation factors RPB2, TFIIS, and SPT5 enhance usage of upstream poly(a) site 
in yeast (Cui & Denis 2003) . Additionally, ELL2 (eleven-nine- teen lysine-rich leukemia gene 2) 
has been shown to modulate the usage of the proximal poly(A) site and increase exon skipping 
in IgH, by competition between the mechanisms of alternative polyadenylation and splicing 
(Martincic et al. 2009).  
The Martincic et al. and Cui and Denis’s work suggest an impact of elongation factors 
in poly(A) site choice and revealed an all new world of crosstalks between these events. 
Consequently, there is a growing need for studies to assess the role of other transcription 
elongation factors in alternative polyadenylation in other models, like Drosophila, using more 
suitable genes (for instance, genes without splicing - e.g. the polo gene). In this thesis, it is 
proposed to study the impact of both elongation factors dELL and dSpt6 in polo poly(A) site 
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selection, since they both display distinct and crucial roles in transcription elongation and 
therefore would allow a new insight in the mentioned interplay. 
a)  dELL 
Originally isolated from rat liver nuclear extracts, ELL was first identified as a fusion 
partner of the MLL (mixed lineage leukemia) gene in chromosomal translocations associated with 
mixed lineage leukaemias in children and shown later to increase elongation by reducing the rate 
of Pol II stalling during active transcription in acute myeloid leukemia (Thirman et al. 1994; 
Shilatifard et al. 1996).  
To this date, three ELL family members (ELL1, ELL2 and ELL3) have been described 
in mammalian cells, all with biochemical elongation activity but differing in expression pattern  
(Thirman et al. 1994; Shilatifard et al. 1996). In Drosophila melanogaster just a single ELL 
homolog has been identified (dELL) and although it displays significant sequence homology to all 
three mammalian ELL family proteins it is most closely related with ELL2. Its ubiquitous 
expression at all developmental stages suggests that dELL has a widespread role in gene 
transcription during development (Gerber et al. 2001). 
In addition to its structural homology to mammalian ELL family proteins, dELL behaves 
like a functional homolog of mammalian ELL, since it is a nuclear protein that can increase the 
elongation rate of Pol II and it physically interacts with this enzyme (Gerber et al. 2001; Byun et 
al. 2012). This elongation factor has been found to participate in distinct complexes as SEC and 
Little Elongation Complex (LEC) and also proved to have nonredundant functions in vivo (Smith, 
Lin & Shilatifard 2011; Smith, Lin, Garrett, et al. 2011) . 
The impact of dELL in alternative polyadenylation is therefore urgent to investigate due 
to its function  in the enhancement of Pol II elongation rate and its role revealed by the Martincic 
et al.’s work that highlight the connection between the mammalian homolog ELL2 with 
polyadenylation and exon skipping (Martincic et al. 2009). 
b) dSpt6 
Another important molecule in the interplay between alternative polyadenylation and 
elongation is Spt6 (Suppressor of Ty 6), which was one of the first known elongation factors for 
which the role in elongation rate was robustly confirmed in vivo (Ardehali et al. 2009). 
The spt6 gene was initially identified from the Spt genetic screen in yeast. This 
elongation factor has been shown to be present on the body of genes in various model systems 
in a transcription-dependent manner (Saunders et al. 2006; Kim et al. 2004; Kaplan et al. 2005). 
Further evidence for the Drosophila Spt6 (dSpt6) role in transcription elongation showed that it is 
a bona fide transcription elongation factor, which positively stimulates the elongation rate of Pol 
II in vivo, co-localizes with the Ser2 phosphorylated form of CTD on polytene chromosomes, and 
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it is critical for normal development and morphogenesis throughout the life cycle of Drosophila 
(Andrulis et al. 2002; Yoh et al. 2007; Ardehali et al. 2009; Dronamraju & Strahl 2014). In addition, 
dSpt6 can regulate histone modifications by acting as a platform for histone modifiers or by 
performing a molecular connection between histones and template DNA (Kato et al. 2013). Taking 
previous studies into account, Spt6 is also suggested to be critical to transcription termination 
(Ardehali et al. 2009). 
The interplay between transcription elongation and alternative polyadenylation ought to 
be quite complex. Therefore, a complete understanding of the role of elongation factors, such as 
Spt6, and affect poly(a) signal selection is crucial to expose such elusive connection. 
3.3. The integration between kinetic and recruitment models 
The coexistence of both models (kinetic and recruitment) has been more recently 
proposed in an integrated model for splicing. Indeed, some findings suggests a strong connection 
between transcription and splicing that might be the consequence of a combination of the two 
models discussed above, since  some splicing factors are able to alter the transcriptional 
elongation rate and introns are necessary for efficient Pol II transcription (Nogués et al. 2003).  
Truly, the interplay between alternative polyadenylation and elongation is likely to also 
be integrated both by elongation rates and elongation factors, in a bidirectional crosstalk between 
the kinetic and recruitment models (Moreira 2011). The interdependence between elongation and 
alternative polyadenylation events is emphasized by the finding that  mutations in 
cleavage/polyadenylation factors lead to inefficient transcriptional elongation and processivity 
(Luna et al. 2005).  
It is well known that the Pol II enzyme exhibits a dynamic behaviour by displaying 
different rates, CTD modifications, differential recruitment of accessory factors or even by 
undergoing reversible modifications. Interestingly, the present panorama of insight suggests that 
this dynamic behaviour of Pol II can affect alternative polyadenylation regulation in a bidirectional-
manner. Definitely, it is the interplay between the dynamic behavior of Pol II and alternative 
polyadenylation that holds one of the most interesting questions in the field: how mechanistically 
alternative poly(A) sites are selected.  
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Chapter 2  
Objectives 
The work described in this thesis was aimed to understand the interaction between 
transcriptional elongation and alternative polyadenylation. This was addressed using the 
Drosophila polo as a gene model, by assessing the impact of a mutant Pol II with an 
increased elongation rate and by depletion of the elongation factors dELL and dSpt6 in polo 
poly(A) site choice.  
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Chapter 3  
Material and Methods 
1. Drosophila melanogaster stocks  
The fly stocks w1118 (wild-type), RpII215 and RpII140 were obtained from the 
Bloomington Stock Centre. The RpII215 flies carry the C4 mutation in RNA polymerase II 215kD 
subunit that modifies the amino acid at position 741 from Arg to His (Chen et al. 1993). The 
RpII140 flies carry the S1 mutation in the RNA polymerase II 140kD subunit, modifying the amino 
acid at position 728 from Ser to Cys (Kim et al. 1994). 
All fly stocks were grown at 25oC using standard cornmeal/honey/agar yeast medium 
and maintained by periodically transferring adults to vials with fresh medium. 
1.1. Drosophila Schneider (S2) cells 
The Drosophila Schneider (S2) cells were first isolated in 1972 from a primary culture 
of late-stage Drosophila melanogaster embryos, and many features of this cell line suggest that 
it is derived from a macrophage-like lineage (Schneider 1972; Zanoni et al. 2009). Today, the 
relevance/potential of this cell line in the molecular biology field is undeniable. 
a) Cell culture 
Cells were grown as a loose, semi-adherent monolayer in 25 cm2 tissue culture flasks 
(Sarstedt) or 6 well plates (Frilabo) and maintained at 25ºC without CO2 in Schneider’s Insect 
Medium (with L-glutamine and sodium bicarbonate, Invitrogen) supplemented with 10% (v/v) Fetal 
bovine serum (FBS) (Invitrogen). 
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b) Cryopreservation of S2 cells 
Cells were grown to sub-confluency (approximately 1-2 x 107 cells/ml in 5 ml), and 
harvested by centrifugation at 1200 rpm for 5 min. Regular growth medium was discarded and 
cells were resuspended at approximately 1.1 x 107 cells/ml in freezing medium (Schneider’s Insect 
Medium with 10% FBS and 10% Dimethyl sulfoxide (DMSO) ). The cell suspension was aliquoted 
to cryovials (Simport) and stored first at -20°C for 24h and finally at -80ºC for long term storage.   
c) Thawing of S2 cells 
The S2 cells cryovial was quickly placed in a 37°C water bath and the cells were 
transferred to 5 ml of warm regular growth medium immediately after thawing. The cells were 
centrifuged at 1200 rpm for 5 min, resuspended in 5ml of regular growth medium and finally 
transferred to a 25 cm2 cell culture flask. 
 
 
2. Total RNA extraction  
 
Total RNA isolation from flies or S2 cells was performed with TRIzol Reagent 
(Invitrogen) according to manufacturer’s instruction with some modifications. Briefly, 20 male adult 
flies were collected and frozen in 200 µL of TRIzol at -80ºC. After thawing, flies were homogenized 
with a disposable plastic pestle and 800 µL of TRIzol was added. The isolated RNA was quantified 
in a Nanodrop 1000 Spectrophotometer (Thermo Scientific) by measuring the absorbance at 260 
nm (A260).  
In order to eliminate any possible DNA contamination, 1 µg of the newly isolated RNA 
was treated with treated with Deoxyribonuclease I (DNAse I) (Roche) for 30 minutes at 37oC, 
according to manufacturer’s instruction. The reaction was stopped by adding [[2-(Bis-
carboxymethyl-amino)-ethyl]-carboxymethyl-amino] acetic acid (EDTA, pH 8.0, final 
concentration 8 mM) and incubating for 10 minutes at 75ºC, to heat inactivate the DNase I. 
Additionally, the integrity of the RNA isolated was assessed using Experion (BioRad). 
 
2.1. cDNA synthesis 
Complementary DNA (cDNA) was synthesized using the 1 µg of DNAse I treated RNA 
by adding 1 µl of Random Hexamers (50 µM, Sigma-Aldrich), 1 µl dNTPs (10 mM, Thermo 
Scientific) and RNAse free water (Thermo Scientific) to a final volume of 14 µl. The mixture was 
incubated for 5 minutes at 65ºC and 4 µl of 5x cDNA synthesis buffer (Invitrogen), 1 µl of 
Dithiothreitol (DTT, Invitrogen), 0.5 µl of RiboLock RNase Inhibitor (40 U/μL, Thermo Scientific) 
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and 0.5 µl of SuperScript III Reverse Transcriptase (200 U/μL, Invitorgen) was added to a final 
volume of 20 µl. Afterwards, the mixture was incubated for 5 min at 25ºC, 60 min at 50ºC and 15 
min at 70ºC to in a 48-well TPersonal Thermocycler (Biometra). cDNA was stored at -20ºC. 
2.2. Polymerase Chain Reaction (PCR) 
The polymerase chain reaction (PCR) was performed by adding 1 µg of cDNA, 2 µl of 
MgCl2 (25 mM), 1 µl dNTPs (10 mM), 1 µl of each oligonucleotide (10µM) (Table A1, see 
Appendix), 2 µl of Green GoTaq Reaction Buffer (Promega), 2 µl of GoTaq DNA Polymerase (5 
U/µl, Promega) and double-distilled sterile water (ddH2O) up to 20 μl. The reaction was performed 
in a 48-well TPersonal Thermocycler (Biometra), with the thermal cycling conditions of 95ºC for 2 
minutes, followed by 30 cycles of: 1 min at 95ºC, 30 sec at the optimized temperature for each 
primer pair and 72 ºC for 1 min. A final extension was performed at 72ºC for 5 min. Furthermore, 
PCR products were analysed by gel electrophoresis on 1.5% Tris-acetate-EDTA (TAE) agarose 
gel stained with SYBR safe (Life Technologies). 
2.3. Real-time PCR reaction (qPCR) 
Gene expression quantifications were performed by real-time PCR reaction (qPCR). 
Each reaction contained 1 µL of the synthesized cDNA, 5 µL SYBR Select Master Mix (Life 
Technologies) and ddH2O up to 10 μL, with variable concentrations of each oligonucleotide pair: 
0.15 µM of polo total, CG6024 total and 7SL; and 0.5 µM of polo pA2 and CG6024 pA2.  
The primers polo total and CG6024 total were designed to anneal in the end of the 
coding region, which allowed to measure all the mRNA isoforms produced by each gene. 
Additionally, these primers anneal to exons on both sides of an intron to allow differentiation 
between amplification of cDNA and potential genomic contamination. The polo pA2 and CG6024 
pA2 primers were designed to allow only the quantification of the long isoform of each gene.  
The samples were run on a StepOne Real-time PCR System (Applied Biosystems) 
using the following program: 50ºC for 2 min, 95 ºC for 2 min, 40 cycles of 95ºC for 15 sec and 1 
min 58ºC. The instrument was also programmed to include a melting profile immediately following 
the thermal cycling protocol, in order to create a complete melting curve. 
It should be highlighted that cDNAs were tested in triplicate and “no template” controls 
were always analysed to ensure that the signal generated was specific and not derived from cDNA 
only and not from primer-dimers, genomic DNA, or any of the cDNA reagents. 
The qPCR reaction efficiency using specific oligonucleotides was evaluated by 
performing a standard curve with 10-fold serial dilutions of cDNA. In an optimal reaction the DNA 
double in each cycle (n) and consequently the dilution factor is equal 2n (Bio-Rad Laboratories 
2006). Thus, with a perfect efficiency (E=2) the 10-fold serial dilutions standard curve’s slope is -
3.32, since 23.32 = 10. Equation 1 was used to calculate the qPCR efficiency using this primer pair 
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(E) and only when the efficiency is between 1.9 and 2.1 the reaction is considered efficient (Bio-
Rad Laboratories 2006). 
E= 10 (-1/slope)     Equation 1  
Generally, two quantification strategies are applied to gene expression quantification 
via qPCR, an absolute or a relative quantification (Pfaffl 2004), the latter was used in this study.  
The relative expression of a gene can be calculated with Equation 2: 
 
Relative expression= 2 -∆Ct = 2 – [Ct target gene-Ct reference gene]test condition          
Equation 2 
 
Where Ct is the number of cycles required to reach a fluorescence threshold during the 
exponential phase of amplification (Livak & Schmittgen 2001) . The -ΔCt method provides the 
expression of a target gene in relation to a reference gene and assumes a maximal reaction 
efficiency (100%, E = 2). 
Additionally, mathematical equations based on the comparison of the distinct cycle 
differences are also established to assess the relative expression ratio (R) (Equation 3).  If 
maximum primer efficiency is assumed (Etarget=Ereference=2), then the Equation 3 can be presented 
in a simpler form (Equation 4). Additionally, under the conditions of Equation 5, the Equation 4 
can be simplified in Equation 6 where the amount of target is normalized to an endogenous 
reference and relative to a calibrator (non-treated or scramble transfected cells).  The explained 
process is the -∆∆ Ct method and it generates a normalized fold expression,  in which  values 
higher than 1 mean an increase of expression of the target gene in the specific  condition  
relatively  to  the  calibrator,  while  values  lower than 1  translate  decrease of expression. 
 
𝑅 =
(𝐸 𝑡𝑎𝑟𝑔𝑒𝑡)∆𝐶𝑡 𝑡𝑎𝑟𝑔𝑒𝑡 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑠𝑎𝑚𝑝𝑙𝑒)
(𝐸 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒)∆𝐶𝑡 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑠𝑎𝑚𝑝𝑙𝑒)
            Equation 3 
 
𝑅 =
2 −[𝐶𝑡 𝑡𝑒𝑠𝑡 𝑔𝑒𝑛𝑒−𝐶𝑡 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑔𝑒𝑛𝑒] 𝑡𝑒𝑠𝑡 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛
2 −[𝐶𝑡 𝑡𝑒𝑠𝑡 𝑔𝑒𝑛𝑒−𝐶𝑡 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑔𝑒𝑛𝑒] 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛
                                    Equation 4 
 
-∆ Ct= - [∆Ct sample -∆Ct control)    Equation 5 
 
𝑅 = 2−∆∆𝐶𝑡       Equation 6 
In the present work, the results were presented using a relative quantification approach. 
The data was analysed using the “-ΔCt method” and “-ΔΔCt method”, assuming the maximum 
efficiency (E= 2). 
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3. RNA interference 
RNA interference (RNAi) is a biological mechanism by which double-stranded RNA 
(dsRNA) induces gene silencing by targeting complementary mRNA for degradation 
(Montgomery 2004). Undoubtedly, this mechanism changed the way researchers study gene 
function and it is an extremely useful tool in the molecular biology field. Luckily, performing RNAi 
assays in S2 cells is simpler than in other cell lines, since these are phagocytic cells that can 
easily take up dsRNA from the cell culture medium (Rocha et al. 2011). 
In this project, gene silencing by RNAi was performed in Drosophila S2 cells to assess 
the possible role of dELL or dSTP6 in polo polyadenylation signal selection process. The 
experimental procedure is depicted in Figure 5. 
 
Figure 5- Schematic representation of RNAi experimental procedure 
3.1. Preparation of DNA template 
Double-stranded RNA was in vitro transcribed from DNA templates obtained from PCR 
products generated by oligonucleotides flanked with T7 RNA Polymerase promoter site on both 
ends. Table A2 (see Appendix) lists all the primers used with their respective sequences. PCR 
reactions were performed as described previously (Materials and Methods, section 5) to a final 
volume of 50 μL. The PCR programs used varied accordingly to each oligonucleotide pair 
requirements (Table A3, see Appendix). 
The PCR products obtained were purified using the QIAquick PCR Purification Kit 
(Qiagen), accordingly with the manufacturer’s instructions and examined on a 1.5% TAE-agarose 
gel. 
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3.2. Production of dsRNA  
The design of the dsRNA molecules was carefully executed for the mRNA of each 
elongation factor studied (dELL or dSpt6), taking into account the possible unspecific targeting, 
targeting of all isoforms and the strongest expression reduction. In addition, a negative control 
was used (DsRED) which did not displayed homology to any of the target mRNAs in the cells. 
In vitro transcriptions were performed using the Ambion Megascript kit (Life 
Technologies) with each reaction containing 1µg of DNA template, 10µl of NTPs (75mM), 2.5µl 
of 10x Reaction Buffer, 2.5 µl of 10x enzyme mix and RNAse free water (Thermo Scientific) up to 
25 μL. The mixture was incubated overnight (16 hours) at 37°C, followed by a 15 min (37°C) 
incubation with 1 l of turbo DNAseI (Ambion Megascript kit) and finally purified with the PureLink 
RNA Mini Kit (Life Technlogies). Annealing of the newly in vitro transcribed RNA was performed 
by a slow annealing program that started with an incubation of 5 min at 96°C and then sequentially 
decreased 2°C each minute until it reached 24°C. Sample where then diluted (1:10) in H2O and 
1 l and 3 l of the diluted material were examined on a 1.5% TAE-agarose gel. 
3.3. Transformation of S2 cells 
For these experiments exponentially growing S2 cells just about to reach confluence 
were used. Cell density was measured and calculated using a Countess Automated Cell Counter 
(Invitrogen) and 1×106 cells per ml of serum free medium was added to each well of a 6-well plate. 
The dsRNAs (Table 2) for each target gene were added and gently mixed by swirling the plate. 
The cells were allowed to settle for 1 h in the incubator. Afterwards, 2 ml of 10% FBS (Invitrogen)-
containing Schneider’s medium (Invitrogen) was added to each well. The plate was then further 
incubated at 25°C for different periods of time (Table 2). 
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Table 2- Amount and incubation period of each dsRNA used in the RNAi assays. 
Target gene dsRNA amount Incubation period 
dell 25µg 120 hours 
dspt6 25µg 96 hours 
DsRED 25µg 
120 hours (as dELL’s control) 
96 hours (as dSpt6’s control) 
 
 
 
4. Statistical Analysis 
The significance of differences in gene expressing was determined by two tailed 
Student’s t-test analysis with 95% confidence intervals. This was performed using GraphPad 
Prism version 6.00 for Windows, GraphPad Software, La Jolla California USA, 
www.graphpad.com. Differences were considered to be statistically significant if p<0.05. 
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Chapter 4  
Results 
1. Assessment of the impact of Pol II elongation in 
alternative polyadenylation 
 
In the present work, it was examined the alternative polyadenylation pattern of polo and 
CG6024 genes in an enhanced Pol II elongation rate scenario, aiming to improve the current 
knowledge in this field and therefore complete the kinetic model proposed by Moreira’s group 
(Pinto et al. 2011; Moreira 2011). 
1.1. RNA extraction optimization 
In order to determine the alternative polyadenylation pattern of different genes an initial 
RNA extraction from flies was performed. In this work, RNA extraction was executed as described 
in the previous section (see Material and Methods), however the DNAse treatment was initially 
done using all the extracted RNA and the incubation period was up to 1hour. In these conditions, 
the RNA obtained displayed high levels of degradation (Figure 6), which did not allow its use in 
further assays.  
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Figure 6- RNA quality assessed by Bio-Rad Experion electrophoresis system. (L) Molecular weight 
ladder (1) RNA extracted and treated with DNAse up to 1hour (2) Sample of high quality RNA.  
 
In order to overcome the obstacle of RNA degradation, different RNA extraction 
methods were tested (Table 3) and different variables were studied: the DNAse enzyme, the 
DNAse incubation period, the DNAse heat inactivation (10 minutes incubation at 75oC), the 
DNAse inactivation with EDTA (pH8, final concentration 8 mM) and the use of Ribolock (Thermo 
Scientific).  
 
 
Table 3- Conditions used in the optimization of the RNA extraction process 
Condition Description 
1 RNA sample with 15 min DNAse treatment  and inactivation with heat and EDTA 
2 RNA sample with 30 min DNAse treatment  and inactivation with heat and EDTA 
3 RNA sample with 60 min DNAse treatment  and inactivation with heat and EDTA 
4 RNA sample with 90 min DNAse treatment  and inactivation with heat and EDTA 
5 RNA sample with 60 min DNAse treatment and inactivation with only with heat  
6 RNA sample with Ribolock, 60 min DNAse treatment  and inactivation with heat and EDTA 
7 Mammalian RNA sample with 60 min DNAse treatment  and inactivation with heat and EDTA 
8 
RNA sample  treated with Turbo DNAse (Life Technologies) (used according to manufacturer’s 
guideline) 
9 RNA sample without DNAse treatment 
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The RNA quality in each condition tested was assessed using the Experion system 
(Figure 7). This system allows rapid and automated results, it requires only a very small amount 
of RNA sample and the integrity of the RNA can be assessed by visualization of the 28S (two 
similar-sized bands in Drosophila) and 18S ribosomal RNA bands (Fleige & Pfaffl 2006; 
Winnebeck et al. 2010). 
In Figure 7, it is possible to observe that the RNA in the sample 9 (not treated with 
DNase) is not degraded, which indicates that, before the DNase treatment, the RNA quality is 
acceptable and the treatment is critical for RNA degradation. Additionally, a different enzyme was 
used (Turbo DNAse (Life Technologies), kindly provided by Professor Jorge Vieira from IBMC; 
sample 8) to determine if the RNA degradation was due the enzyme used. Since some samples 
tested with the regular enzyme did not displayed any RNA degradation, it was excluded the 
hypothesis that the DNase could favour RNA degradation. Notably, between all the incubation 
periods tested, 30 minutes (sample 2) was selected as the most preferable one, since it displayed 
the lower level of degradation and did not showed any genomic contamination. In contrast, longer 
incubation periods (sample 3 and 4) exhibited high levels of degradation. Another variable tested, 
was the EDTA used to inhibit DNase after treatment. It was proved that the EDTA role is crucial, 
since samples without it (sample 5) display higher levels of degradation in comparison with 
samples in the same condition but treated with EDTA (sample 3). Additionally, it was showed that 
the protective role of Ribolock against RNases is not necessary, since sample 6 showed the same 
degree of degradation as the sample without Ribolock (sample 3). To exclude the possibility that 
the poor RNA quality was due the sample type or extraction method, a mammalian sample 
(sample 7) was treated in the same conditions as sample 3. Since the degradation levels of both 
samples was almost the same the named possibility can be ruled out.  
These results allowed to successfully determine the condition in which the RNA 
extraction must be performed in order to achieve RNA that is not degraded and that does not 
display genomic contamination. In conclusion, 30 minutes of DNase incubation must be used, the 
enzyme should be inactivated with heat and EDTA and Ribolock is not necessary. 
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Figure 7- RNA integrity of different RNA extraction conditions tested. (L) Molecular weight ladder (1) 
to (9) RNA extracted and treated according to the conditions described in Table 3. 
1.2. Assessment of alternative polyadenylation in polo and CG6024 
Using RNA extracted from w 1118, RpII215 and RpII140 flies and specific primer pairs, 
the role of Pol II kinetics on poly(A) site usage of polo and CG6024 genes was studied by qPCR. 
a)  polo gene 
In order to study the alternative polyadenylation pattern of polo in the different 
Drosophila strains, primers that differentially measure the total mRNA level and the long mRNA 
isoform were used (polo total and polo pA2 primers) (Figure 9 a). The qPCR efficiency using each 
primer pair was assessed in different conditions, allowing to find the one in which the efficiency 
was between 1.9 and 2.1. 
Regarding the polo total primer pair, it was previously shown that 58ºC could be used 
as annealing temperature (Henriques 2011). Therefore, the first attempt to find the efficient qPCR 
conditions for polo total primer pair, was using 0.15 µM of each primer and 58oC as annealing 
temperature. The efficiency in this condition was calculated as indicated by W. Paff (see Materials 
and Methods) and value obtained was 2.07 (Pfaffl 2001). Additionally, the standard curve used to 
assess qPCR’s efficiency using polo total primers is display in Figure 8, as an example of the 
approach used.  
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Figure 8- Standard curve for polo total primer pair.  A plot of CT against the ln of cDNA, results in a 
straight line. This is a linear regression generated using ten-fold serial dilutions of template and the qPCR 
efficiency using polo primer pair is determined from the slope of the calibration curve. 
Concerning the polo pA2 primer pair, it was also previously shown that 58ºC could be 
used as annealing temperature (Henriques 2011), therefore this temperature was used and 
different primer concentrations were tested. Initially, the qPCR efficiency using polo pA2 primer 
pair was assessed in the same condition stated to polo total primer, however the efficiency 
obtained was 2.33, thus out of the desirable range. Then, the primer concentration was raised to 
0.5 µM, which lead to an efficiency of 1.95. 
In addition to optimize the conditions of polo total and polo pA2 primers, the efficient 
condition using 7SL (reference gene) primers must be determined. In fact, the same conditions 
used to polo total primer pair were tested with 7SL primers and the efficiency achieved was 2.0. 
After measuring and optimizing the qPCR efficiency for each primer pair, qPCRs were 
performed to assess the levels of polo total and pA2 in RpII215, w 1118 and RpII140 flies. 
Figure 9 shows that the polo mRNA levels differ between the fly strains tested. The 
similar mRNA levels of total polo and the decrease in polo pA2 displayed by the RpII215 mutant 
in comparison with w 1118 are consistent with previous work (Pinto et al. 2011). The novelty was 
the comparison between polo total mRNA levels of RpII140 flies and the wild-type counterpart, 
since polo levels decreased 0.6 fold (i.e. 60%) in the flies with an enhanced Pol II elongation rate 
(RpII140). Regarding polo pA2 mRNA levels, the RpII140 mutant showed similar levels to w1118 
(1.08 fold, i.e. 108%). These results suggest that polo short mRNA isoform (polo pA1) is 
decreased in RpII140, since polo total levels decreased but polo pA2 levels were maintained. 
Noteworthy, in RpII140 flies this outcome affects the polo proximal poly(A) site (pA1), which is the 
stronger one (AUUAAA).  
 
Integrating RNA Polymerase II dynamics with alternative polyadenylation 
Joana Troça Correia Maia 
 
34 
 
 
Figure 9-RNA Pol II kinetics with a slower an enhanced transcription elongation rate affects 
polo alternative polyadenylation. a) diagram that illustrate primer positions for qPCR analysis b) polo 
mRNA levels in RpII215, w 1118 and RpII140 flies and a c) polo pA2 mRNA levels in RpII215, w 1118 and 
RpII140 flies. Graph represents fold change of polo mRNAs in adult flies, relative to 7SL mRNA. For all the 
panels, error bars show standard error of the mean (s.e.m.) from at least three independent experiments 
b) CG6024 gene 
The CG6024 gene shows a similar genomic structure to polo, since it contain two 
poly(A) signals in the 3’UTR (information kindly provided by Joel Graber and GenBank, NCBI). 
Therefore, in order to study the alternative polyadenylation pattern of CG6024, primers able to 
differentially measure total polo mRNA level and the long mRNA isoform were used (CG6024 
total and CG6024 pA2 primers). 
It was previously shown that 58ºC could be used as annealing temperature of both 
oligonucleotides CG6024 total and CG6024 pA2 , therefore that was the temperature used in this 
work (Henriques 2011). The efficiency obtained for the CG6024 total primer pair, when tested in 
the same condition stated to polo total primer, was 2.18. In addition, the CG6024 pA2 primer when 
used in the optimized condition of polo pA2 primer, displayed an efficiency of 1.92. 
 After each primer pair‘s efficiency have been determined, qPCRs were performed to 
assess the levels of CG6024 total and pA2 in RpII215, w 1118, and RpII140 flies. In Figure 10, 
RpII215 mutant in comparison with the wild-type counterpart displayed comparable total mRNA 
levels of CG6024 and a decrease in CG6024 pA2, which are consistent with the results already 
published (Pinto et al. 2011). Interestingly, the RpII140 flies in comparison with w 1118 showed a 
significantly decrease in total CG6024 mRNA levels by 0.4 fold (i.e. 40%), and a significantly 
augmentation of CG6024 pA2 levels by 3.3 fold (i.e. 330%). These results suggest that the 
CG6024 short isoform (CG6024 pA1) is reduced in RpII140 flies, since CG6024 total mRNA levels 
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decreased but CG6024 pA2 levels increased. Additionally, these results also reveal a CG6024 
3’UTR lengthening in these mutant flies. 
 
 
Figure 10- RNA Pol II kinetics with a slower and a faster transcription elongation rate 
affects CG6024 alternative polyadenylation. a) CG6024 mRNA levels in RpII215, w1118 and RpII140 flies 
b) CG6024 pA2 mRNA levels in RpII215, w1118 and RpII140 flies. Graph represents fold change of polo 
mRNAs in adult flies, relative to 7SL mRNA. For all the panels, error bars show s.e.m. from at least three 
independent experiments 
 
 
 
2. Study on the role of transcription elongation factors in 
polo alternative polyadenylation 
 
To understand the impact of the elongation factors dELL and dSpt6 in alternative 
polyadenylation, each of these factors was depleted via RNAi from Drosophila S2 cells and then 
changes in polo poly(A) site usage were quantified. 
2.1. Optimization of PCR products  
The in vitro transcription procedure requires a purified DNA template produced by PCR. 
In this thesis, the DNA templates used were specific PCR products for each target gene: dell, 
dspt6 and DsRED. These PCR products were synthesised using primers specific for the target 
genes flanked with T7 promoter regions, able to amplify the sequence of interest from S2 cells 
(dell and dspt6 genes) or from the plasmid pIRES2 DsRed-EGFP (DsRED gene). In order to 
optimize the quality of the PCR products for each target gene, diverse PCR conditions were tested 
(primer and sample concentrations, PCR programs) and modifications in the purification method 
were performed.  
Taking into account that some PCR products displayed subtle primer dimer bands, it 
was tested the usage of guanidine hydrochloride in the purification procedure, as suggested by 
the manufacturer. Figure 11  shows the result of the purification of dell PCR product with and 
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without guanidine hydrochloride, and both conditions display the expected band at 500bp and no 
primer dimer band. 
 
Figure 11- PCR product purification. 
First lane is the molecular ladder of 100 to 1000bp. Purification using guanidine hydrochloride (lane on the 
left) and not (lane on the right).  
 
Ultimately, all the mentioned optimization steps lead to PCR purified products without 
unspecific bands and primer dimers as illustrated in Figure 12. In fact, in this figure it is possible 
to observe the expected band of ~1000bp in the non-purified and purified PCR products of dSpt6 
and the expected band of ~500bp of non-purified and purified PCR products of dell and DsRED. 
These PCR products were further used in in vitro transcription assays that resulted in the dsRNA 
shown in Figure 13 .  The dsRNA for each target gene were displayed using 1µl and 3 µl of sample 
to assure that the band was visible. For all the dsRNAs it is possible to observe the expected 
band (~1000bp for dspt6 and ~500bp for dell and DsRED).  
 
 
Figure 12 – Quality of PCR products.  
First lane is the molecular ladder of 100 to 1000bp. a) before purification. b) after purification 
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Figure 13-dsRNA after the in vitro transcription reaction.  
First lane is the molecular ladder of 100 to 1000bp.  dsRNA after reaction using 1µL (left lane) or 3 µL 
(right lane) of sample 
2.2. Optimization of the RNAi assays 
The knockdown assays here described were designed to be executed on exponentially 
growing S2 cells, therefore the proliferation state of the cells was analysed (Figure 14). 
In Figure 14 it is possible to observe an initial phase from day 0 to day 2, in which the 
growing rate is moderated. Then, between the 2nd and 3rd day, an exponential phase begins with 
an enhanced proliferation rate that slows down in the last phase between the 3rd and 4th day. 
 
 
Figure 14- Graphic representation of S2 cells proliferation 
 
After determining the S2 cells exponential growth phase, an optimization of the RNAi 
assays was in order. It was used 25 µg of each dsRNA and optimized the incubation period for 
each target.  
To validate the knockdown efficiency in every experiment qPCR were performed, using 
primers to measure dell and dspt6 mRNA levels in the dsRNA treated sample and control sample 
(treated with DsRED dsRNA). Both dell and dspt6 primer pairs were optimized using 58ºC as 
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annealing temperature and 0.15 µM of each primer, and the efficiency was 2.07 to dell primer pair 
and 1.9 dspt6 primer pair. 
The Figure 15 shows dell knockdown efficiency using different dsRNA incubation 
periods. The knockdown efficiency at 96h was 34% and at 120h was 40%, which means that the 
dell knockdown efficiency is greater at 120h. This is in agreement with the literature, since Smith 
et al. reached 50% of dell knockdown when using 26 cells/ml that were serum starved, treated 
with  3 boosts of 10 µg dsRNA and  harvested at 120 h. Note that the dsRNA used in this work 
and the ones used by Smith et al. target different dell regions (Smith, Lin, Garrett, et al. 2011).  
In order to improve the 40% efficiency, the dsRNA amount was rise up to 30 µg, which 
was added to the cells in 10 µg boosts at 0h, 48h and 96h (Figure 15). The knockdown efficiency 
did not improve, in fact no knockdown was achieved.  
 
 
Figure 15- dell knockdown efficiency. Using different dsRNA incubation times (96h and 120h) and in 
single or boosted administrations. Graphs represents fold change of dell mRNAs in samples treated with 
dell or DsRED dsRNA, relative to 7SL mRNA.  
 
The dspt6 knockdown efficiency at 96 and 120h is illustrated in Figure 16. The 
knockdown efficiency at 96h is 60% and at 120h is 2%. It is noteworthy that an increase of cell 
death was observed in the cells treated with dspt6 dsRNA in comparison with the cells treated 
with DsRED (data not shown). In addition, the level of cell death was higher in the sample treated 
with dspt6 dsRNA at 120h then at 96h.  
The 60% dspt6 knockdown efficiency is in agreement with the literature, since Ardehali 
et al. reached 70% of dspt6 knockdown when using 16 cells/mL with serum free medium, treated 
with 10µg of dsRNA and harvested at 84h (Ardehali et al. 2009). Noteworthy,  the dsRNA used in 
both works are distinct and target different dspt6 regions (Ardehali et al. 2009). 
 
Integrating RNA Polymerase II dynamics with alternative polyadenylation 
Joana Troça Correia Maia 
 
39 
 
 
Figure 16- dspt6 knockdown efficiency. Using dsRNA incubation times (96h and 120h). Graphs 
represents qPCR quantification of dspt6 mRNAs in samples treated with dspt6 or DsRED dsRNA, relative 
to 7SL mRNA.  
2.3. Impact of elongation factors in polo alternative polyadenylation 
pattern 
Once the knockdown of elongation factors where efficiently performed the effect in polo 
poly(a) site choice was assessed by qPCR. 
a) dELL 
Figure 17 displays total polo and pA2 mRNA levels in cells treated with dell and DsRED 
dsRNA for 120h.  Similar polo total mRNA levels were observed in both samples (Figure 17a) 
indicating that this elongation factor does not affect polo mRNA levels. Interestingly, depletion of 
dell causes a 1.7 fold (i.e. 170% fold) increase in polo pA2 mRNA levels (Figure 17b)). 
These results indicate that dELL modulates polo alternative polyadenylation and 
suggest that polo short isoform (polo pA1) is reduced when dell is diminished because polo total 
mRNA levels are the same but polo pA2 levels are increased. Therefore, dELL is enhancing the 
usage of polo proximal poly(A) site. 
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Figure 17- The elongation factor dELL affects polo alternative polyadenylation. a) polo total 
mRNA levels in samples treated with dell or DsRED dsRNA for 120h. b) polo pA2 mRNA levels in samples 
treated with dell or DsRED dsRNA for 120h. Graphs represent fold change of polo mRNAs in samples treated 
with each dsRNA relative to 7SL mRNA. 
b) dSpt6 
In Figure 18 it is displayed polo total and pA2 mRNA levels in samples treated with 
dSpt6 and DsRED dsRNA for 96h.  Similar polo total mRNA levels were detected in both samples 
(Figure 18a). Additionally, polo pA2 mRNA levels were different between samples, since the 
sample where dspt6 was depleted displayed higher levels of polo pA2 than the control (6.8 fold) 
(Figure 18b). 
Unfortunately, these results are not acceptable for a correct interpretation of the 
phenomena in study, since the expression of the reference gene used (7SL) was not invariant 
under the experimental conditions described (Bustin et al. 2009). 
 
 
Figure 18- Elongation factor dSpt6 affects polo alternative polyadenylation. a) polo total 
mRNA levels in samples treated with dspt6 or DsRED dsRNA for 120h. b) polo pA2 mRNA levels in samples 
treated with dspt6 or DsRED dsRNA for 120h. Graphs represent qPCR quantification of polo mRNAs in 
samples treated with each dsRNA, relative to 7SL mRNA. 
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Chapter 5  
Discussion and Future Perspectives 
Alternative polyadenylation is a co-transcriptional event involved in the quantitative and 
qualitative regulation of gene expression in a diversity of biological processes. Through the 
selection of single or alternative poly(A) site in one transcription unit this process presents a major 
player influencing the dynamics of gene regulation (Millevoi & Vagner 2010; Shepard et al. 2011). 
In addition, transcription elongation is also described as capable of adjusting the outcome of gene 
expression, since it provides a mechanism for the modulation of cellular RNA levels (Kwak & Lis 
2013; Svejstrup 2013). Interestingly, an intense and relevant cross-talk between both processes 
have been described (Luna et al. 2005). 
The work presented in this thesis aims to understand the impact of an increased Pol II 
elongation rate in alternative polyadenylation. In addition, it was investigated the role of specific 
transcription elongation factors as relevant players. 
In order to evaluate alternative polyadenylation in both models used in this project, the 
RNA was isolated using TRIzol, since this approach maintains the integrity of the RNA and is also 
particularly advantageous in situations where cells or tissues are enriched for endogenous 
RNases (Rio et al. 2010).  
The RNA extraction condition in which RNA is not degraded and does not displayed 
genomic contamination was optimized. The presence of EDTA was important in the method, since 
samples treated with EDTA displayed lower levels of RNA degradation. The crucial role of EDTA 
is due the fact that this compound chelates divalent metals (primarily magnesium and calcium) 
which are co-factors and essential for DNase and RNAse activity. Additionally, it was shown that 
long DNase incubation periods display high levels of degradation, presumably because high 
temperatures can cause RNA denaturation and activate a few RNAses. 
One of the aims of this project was the assessment of the alternative polyadenylation 
pattern in an enhanced Pol II rate scenario. In order to fulfil this goal, the flies used were mutants 
engineered to elongate at different speeds: 50% slower (RpII215 flies) and 50% faster (RpII140 
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flies). Additionally, qPCRs were performed with DNA synthesised from RNA extracted from 20 
male flies. It should be noted that only males were used in order to discard the variability that 
would arise from the usage of female flies, since sex-specific expression of alternative transcripts 
in Drosophila is a well-known phenomenon, in which gene expression profiles are dominated by 
the reproductive differences between males and females (McIntyre et al. 2006; Smibert et al. 
2012).  
The RpII140 flies in comparison with the wild-type showed a decrease in polo levels 
and similar polo pA2 mRNA levels, which suggests that polo pA1 is decreased. Interestingly, this 
effect is observed on the stronger poly(A) site (pA1).  
To better understand these results and assess the role of the strength of the poly(A) 
signals in the mechanism, the CG6024 gene was used. This gene displays a similar genomic 
structure with polo, as it contains two poly(a) sites in the 3’UTR, however the strength of the 
poly(A) signals are opposite to the one exhibit by polo . Indeed, in CG6024 pA2 display a 
canonical signal (AATAAA) and pA1 shows a variant of it, consequently pA2 signal is stronger 
than pA1 (information kindly provided by Joel Graber and GenBank, NCBI) . 
The RpII140 flies in comparison with w1118 showed a decrease in CG6024 total mRNA 
levels and an increase of CG6024 pA2 levels, which suggest that CG6024 pA1 is reduced. These 
results also reveal a CG6024 3’UTR lengthening in these mutant flies. 
The results here presented may constitute preliminary evidence that the decrease of 
total mRNA levels is a general event when the Pol II processivity is enhanced, which presumably 
can be due a decrease in the mRNA 3’end processing efficiency (either or in both cleavage and 
polyadenylation) (Proposed working model in Figure 19). We propose that a decrease in the 
mRNA 3’end formation efficiency can be a direct consequence of the enhancement of the 
elongation rate. In that scenario, the efficiency of nucleotide selection and incorporation and thus 
the nascent RNA production is faster.  It is possible then that the recognition of the poly(A) signal 
- which is necessary for transcription termination - is affected, which could lead to an increased 
Pol II read-through and consequently a decrease in total mRNA levels. In fact, a similar 
relationship between elongation rate and splicing efficiency have been described by Braberg et 
al., since it was proved in yeast that fast Pol II mutations result in diminished splicing efficiency 
(Braberg et al. 2013; Moehle et al. 2014). The work here presented suggests that some valid and 
similar conclusions can also be applied to mRNA 3’end processing (cleavage and alternative 
polyadenylation).  
In RpII140 flies, the decrease of total mRNA levels may also be due to an indirect effect 
of RNA quality control mechanism. To clarify this question, future studies should be performed to 
assess the expression of RNA quality control genes in RpII140 flies in comparison to wild-type. 
Using qPCR it could be assessed the expression of genes such as Upf1, which is crucial to RNA 
quality control because it is part of the so-called “decay-inducing complex” that targets mRNA for 
decay (Isken et al. 2008; Rehwinkel et al. 2005; Isken & Maquat 2007). If the expression of Upf1 
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is enhanced in RpII140 flies that could suggest that the decrease of total mRNA levels is due a 
regulatory mechanism of RNA quality control. 
For every transcript total RNA levels are the result of a fine-tuned balance between RNA 
synthesis and RNA decay, and the results here shown reflect what happens at a steady state. 
Therefore, it would be important in the future to analyse nascent transcripts, since analysis 
performed with total cellular mRNA show results with poor resolution of the underlying 
mechanisms of the alterations in cellular response and a bias towards detecting up-regulation of 
short-lived transcripts.  
An enhanced Pol II elongation rate leads to a subtle decrease in the usage of the 
proximal site (pA1) in polo and a more significant one in CG6024. Additionally, in the CG6024 
gene the distal site is preferentially used in RpII140 flies, which indicates that there is a shift in 
the alternative polyadenylation pattern. Presumably, the statistical significant shift in the poly(A) 
site usage in CG6024 is due to the distal signal (pA2) higher strength, and the subtle pA1 
reduction in polo is due the weakness of the distal signal.  
The different outcomes in both genes studied also suggest that in addition to signal 
strength other regulatory elements (e.g. USE, DSE, various polyadenylation factors) can affect 
poly(A) site choice in an enhanced Pol II elongation rate scenario. The relevance of such elements 
in alternative polyadenylation was proved by Hall-Pogar et al., by showing that the synthesis of 
both cox-2mRNAs seems to be tissue-specific and that the expression of the shorter mRNA is 
dependent of an USE near the proximal poly(A) site (Hall-Pogar et al. 2005). Moreover, polo 
contains an USE that affects APA (Moreira and coll., unpublished data). Therefore, future studies 
must be performed with other genes that in addition to the two poly(A) sites in the 3’UTR, should 
also exhibit similar regulatory elements (e.g USE and DSE). This would allow to assess if these 
elements are key in the modification of the alternative polyadenylation pattern when the Pol II 
processivity is enhanced. The selection of such genes could be performed bioinformatically, by 
performing a RNA-sequencing (RNA-seq). Using the gene selected and mutating their USE 
region, qPCRs studies could be performed to assess if the presence of e.g. USE correlates with 
alternative polyadenylation alterations when the Pol II rate is changed. 
It is possible that the point mutation in Pol II in the RpII215 and RpII140 flies alter 
interactions with specific factors that are differently recruited to the elongating Pol II and thus 
affect the alternative polyadenylation event. A pertinent study would be to assess differences in 
the recruitment of some key factors in polyadenylation, in both mutants. It could be interesting to 
perform chromatin immunoprecipitation (Co-Ip) assays, with antibodies against Pol II and e.g. one 
CPSF’s subunits, since this factor is required for poly(A) signal recognition, endonucleotic 
cleavage and polyadenylation reactions. If alternative polyadenylation effects observed in RpII140 
were strictly due differences in the elongation rate, one would expect this mutant to have similar 
levels of CPSF recruited to the Pol II than wild-type and RpII215.  
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To the best of our knowledge, this study represents the first example where an 
enhanced Pol II transcription elongation rate displays an impact in the mRNA 3’end formation 
efficiency and alternative polyadenylation pattern. It is noteworthy that in splicing it is described 
that not all genes respond to Pol II transcription rate modifications (Moehle et al. 2014), which can 
also be the case  for alternative polyadenylation. Even though it is technically difficult to measure 
gene-specific transcription elongation rates in vivo, it would probably be found that genes affected 
by Pol II rate already would be genes in which elongation rate is modified. Alternatively, perhaps 
genes that did not respond to changes in Pol II rate may have a powerful mechanism for 
maintaining normal Pol II elongation rate even in the context of the Pol II mutations, to assure the 
maintenance of protein levels (Moehle et al. 2014). 
Taken together, all these evidences suggest that kinetic coupling of transcription 
elongation and alternative polyadenylation is indeed a relevant regulatory pathway of gene 
expression.  
 
 
 
 
Figure 19- Hypothetical model of how Pol II elongation rate impacts 3’end formation efficiency. (See 
text for details) 
 
The results presented in this thesis elucidate the function of elongation factors in 
alternative polyadenylation. Based on the present literature, dELL and dSpt6 were the elongation 
factors selected to study and RNAi methodology was performed to knockdown each of these 
factors from Drosophila S2 cells, in order to assess their effect in polo alternative polyadenylation 
pattern.  
One of the elongation factors studied in this project was dELL, which increases the 
transcription elongation rate of Pol II, participates in SEC and LEC and also has a widespread 
role in gene transcription during development (Smith, Lin & Shilatifard 2011; Smith, Lin, Garrett, 
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et al. 2011). It should be highlighted that dell was previously shown to be an essential gene in 
Drosophila, and homozygous for loss-of-function alleles die at the end of embryogenesis or in 
early first instar larvae, therefore the RNAi technique here performed was important to assess 
dELL role in alternative polyadenylation (Eissenberg et al. 2002). In fact, knockdown dell by RNAi, 
typically reduces, but does not eliminate, the targeted gene products. It would be interesting to 
perform tissue-specific RNAi and/or overexpression of dell in flies to investigate its effect in 
alternative polyadenylation in the context of the whole organism. 
In order to accomplish the strongest dell depletion possible, various knockdown 
conditions were tested. It was used 30µg and boosted administrations in order to enhance the 
knockdown efficiency, however the new conditions did not lead to dell depletion, probably 
because the dsRNA was degraded when the assays were performed, since RNA samples are 
more prone to degradation that DNA samples. In fact, by using this approach it would be expected 
that the knockdown efficiency achieved would be equal or higher than 40%, since higher dsRNA 
amount was used and it was administrated at 3 distinct time points. 
Our results suggest that dELL enhances the usage of polo proximal poly(A) site. 
Similarly, these results are in agreement with the work performed in dELL mammalian homolog 
ELL2, which suggests a conservation of the mechanisms. It was shown that ELL2 enhance usage 
of the proximal poly(A) site of IgM and it was  proposed that  the loading of ELL2 and CstF-64 on 
Pol II was interligated and it caused that effect in proximal poly(A) signal usage (Martincic et al. 
2009). 
The impact of dELL in poly(A) site usage could presumably be due to a direct action of 
this factor in alternative polyadenylation , which suggests a novel role for dELL as a relevant 
player in this mechanism. Nevertheless, dELL exhibit various roles that can influence the results 
obtained, therefore it is plausible that the correspondence between dell knockdown and the 
impact in alternative polyadenylation is due to an indirect effect and not a direct action of this 
factor on the pre-mRNA.  Indeed, dELL participates in SEC, which probably can explain the 
described outcome:  when dell is reduced SEC assembly is compromised and Pol II is 
destabilized, which may affect the poly(A) site choice (Byun et al. 2012). Other possibility, is 
concerning dELL’s role in the Pol II elongation rate, therefore when dell is knockdown the Pol II 
elongation rate is affected and that influences poly(A) site usage, as previously shown. Finally, 
dELL is also suggested to promote loading of various polyadenylation factors as CstF-64 on the 
transcription machinery, which can enhance the usage of the proximal poly(A) site of polo. This 
is accordant to what was published by Martincic et al. regarding the ELL2, since it was suggested 
that this factor influences the poly(A) site choice of IgM by affecting the loading of CstF-64 onto 
Pol II (Martincic et al. 2009).  
In order to clarify the direct / indirect role of dELL in poly(A) site choice, further studies 
should be performed. To assess if dELL presence in SEC is affecting alternative polyadenylation, 
depletion of other SEC components (e.g. Lilli) using RNAi could be performed. If the same 
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tendency was obtained then probably dELL acts in poly(A) site choice indirectly as a SEC member 
(Luo et al. 2012). On the other hand, if dELL impacts on the elongation rate per se and this is 
responsible for alternative polyadenylation alterations, then the reduction of another elongation 
factor that stimulates positively Pol II rate, such as TFIIF, would lead to a similar outcome as the 
one here observed (Bengal et al. 1991; Tan et al. 1995). Additionally, if the rational of ELL2 
described by Martincic et al. also applies for dELL, then this factor acts indirectly in poly(A) site 
choice by affecting the loading of CstF-64 (Martincic et al. 2009). To prove that, CstF-64 could be 
depleted by RNAi assays and if similar results to dell knockdown were obtained, then dELL 
influences indirectly alternative polyadenylation by affecting the loading of CstF-64. Furthermore, 
to verify that the effect described in this document is a general effect more genes should be 
studied and ultimately high-throughput RNA-seq methodologies should be employed.   
The findings reported in this thesis show that dELL is one of the few transcription 
elongation factors described as enhancing promoter proximal poly(A) site ‘choice’. Therefore, the 
results here presented were incorporated into a working model (Figure 20). 
 
 
 
 
 
Figure 20- Working models on the role of dELL in poly(A) site choice. Upper panel: in dELL presence 
scenario Lower panel: in dELL depletion scenario a) absence of dELL have a direct impact in alternative 
polyadenylation b) lack of dELL affects SEC assembly and consequently Pol II stabilization c) dELL depletion 
can reduce Pol II elongation rate d) dELL reduction disturbs Cstf64 loading to CTD. (See text for details) 
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The other elongation factor studied in this project was dSpt6, which positively stimulates 
the elongation rate of Pol II, regulates histone modifications and is critical to normal transcription 
termination (Ardehali et al. 2009).  
As previously mentioned, the dspt6 knockdown affected the cells viability which 
highlight the relevance of this elongation factor for cell survival. Unfortunately, from the data 
presented nothing can be extrapolated since the expression of the reference gene (7SL) 
fluctuated between the samples, which is not the recommended behaviour (Bustin et al. 2009). 
This variation may be due to cell death already mentioned and in the future, these studies should 
be repeated using other reference gene, e.g. rp49 gene.  
Regardless the outcome of these future studies, those results must be carefully 
analysed because a possible effect of dspt6 knockdown in alternative polyadenylation, may be 
due a direct action of this factor but also to its role in termination or as a histone modifier. Indeed, 
dspt6 depletion will probably affect the chromatin structure, since dSpt6 remove nucleosome 
barriers by direct interaction with histones H3 and H4. Therefore, dSpt6 absence could affect Pol 
II action by making the DNA template unaccessible for productive elongation, which may lead to 
modifications in alternative polyadenylation (Kaplan et al. 2005). To assess if impact of dspt6 
depletion in poly(A) site usage is due to its role as histone modifier, another histone modifiers 
should be tested. 
In addition, dspt6 silencing can also affect the termination process. Therefore, it should 
be investigated the Pol II distribution along the polo gene when dspt6 is depleted by performing 
Chromatin Immunoprecipitation (ChIP) using e.g. α-Rpb3 Pol II antibody. Transcription 
termination in high eukaryotes largely depends on the presence of a poly(A) signal. When Pol II 
terminates transcription it disengages from the DNA template and this effect is observed by a 
decrease in Pol II occupancy in the 3’UTR, downstream of the poly(A) signal. Therefore, it will be 
possible to asses if the alternative polyadenylation outcome can be due to the termination defect 
and not due a direct action of dSpt6. Additionally, spt6 mutations are described to impair 
transcription read-through (Kaplan et al. 2005). Since snap is polo downstream gene, snap levels 
must be also assessed by nuclear run-on, which measures nascent spt6 mRNAs, polo mRNAs 
and snap mRNA readthrough transcripts. If different levels are obtained when dspt6 is depleted, 
then probably the impact of dSpt6 in poly(A) site choice is due to a defect in transcription read-
through. 
The RNAi studies performed to assess the role of dELL and dSpt6 in alternative 
polyadenylation, should be also complemented with western assays to confirm the decrease in 
the protein levels (Professor Ali Shilatifard and Professor John Lis kindly provided dELL and dSpt6 
antibodies, respectively). In addition, it would be interesting to perform in vivo studies, using RNAi 
mutants for each named factor and assess if there is an interesting outcome that would 
complement the in vitro studies. 
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As previously mentioned, the coexistence of both kinetic and recruitment approaches 
has been proposed in an integrated model. In the context of this project, an interesting experiment 
to perform would be to assess if there is a differential recruitment of elongation factors (e.g. dELL 
and dSpt6) in the RpII215 and RpII140 flies mutants, by Co-IP and ChIP assays. Hopefully, this 
and other experiments will give more insight in the bidirectional crosstalk between the kinetic and 
recruitment model in alternative polyadenylation, by elucidating the relevance of the interaction of 
elongation rates and elongation factors in alternative polyadenylation. 
 
 
Many emerging concepts justify the renewed interest in the cross-talk between 
transcriptional elongation and alternative polyadenylation. We hope that the results here 
presented highlighted that alternative polyadenylation and transcription elongation can be 
recognized as key mechanisms for eukaryotic gene regulation.  
 In the future, the knowledge obtained from how alternative polyadenylation and 
elongation interact, will certainly help to gain a novel insight on the molecular mechanisms 
involved in regulation of gene expression, and hopefully also to develop new tools to understand, 
detect and treat some human disease. 
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Appendix  
Table A1- Oligonucleotides used during the experimental work for PCR and qPCR. All primers were obtained from 
Sigma- Aldrich. 
  Sequence (5’- 3’) 
polo total Forward CCGTACAACATGTGCCGTAG 
Reverse CTTTAGACACGCCGTTCTCC 
polo pA2 Forward ACGTGTTTCGAAATGCCTAT 
Reverse ACACTTAAACACTTTGCAGCAG 
CG6024 total Forward CACCGCACTCCACACAACTA 
Reverse ATTGGGATGTCCGGTTCC 
CG024 pA2 Forward CAGTAACGGAAGACCCGAAA 
Reverse GGTCCAAAGGAGGGTGAAAT 
7SL Forward TTGGCTAAGGAGGGATGAAC 
Reverse CTACTGCCTACCACGGGAAC 
dELL Forward TGTGGAACGATGTGGACGAG 
Reverse GCGGTGTCAGATTTTGAGGC 
dSpt6 Forward GGCCGTCTCCGATAGTAGC 
Reverse TCGATCAGATCTTTGAGCTCTTC 
 
 
Table A2- Oligonucleotides used to obtain the DNA templates for the production of dsRNA 
  Sequence (5’- 3’) 
T7- dELL Forward TAATACGACTCACTATAGGGAGAGCGTCAAAGAAGTGCCAGTG 
Reverse TAATACGACTCACTATAGGGAGACGTAGTCCCCGTATCCGTTG 
T7- dSpt6 Forward TAATACGACTCACTATAGGGAGACCGTAACCCCGGTGCCCGAGG 
Reverse TAATACGACTCACTATAGGGAGAGGCTCTTGTGCCAGCTGTCGG 
T7- DsRED Forward GAATTAATACGACTCACTATAGGGAGACTTCAAGGTGCGCATGGAG 
Reverse AATTAATACGACTCACTATAGGGAGAGGACTTGAACTCCACCAGGTAGTG 
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Table A3- PCR programs used to obtain the DNA templates for the production of dsRNA 
 
 
PCR product 
PCR reaction 
Initial 
denaturation 
step (ºC) 
Denaturation 
temp (ºC) 
(step 2) 
Annealing 
temp (ºC) 
(step 3) 
Extension 
temp (ºC) 
(step 4) 
Nº of cycles 
(step 2-4) 
dELL 
95(5min) 95 (30 sec) 53 (30 sec) 72 (1 min) 3 
 95 (30 sec) 55 (30 sec) 72 (1 min) 5 
 95 (30 sec) 57 (30 sec) 72 (1 min) 27 
dSpt6 
95(5min) 95 (30 sec) 55 (30 sec) 72 (1 min) 3 
95(5min) 95 (30 sec) 57 (30 sec) 72 (1 min) 5 
95(5min) 95 (30 sec) 60 (30 sec) 72 (1 min) 27 
DsRED 95(5min) 95(1min) 55 (30 sec) 72 (1 min) 35 
 
